Esperion Therapeutics (ESPR) Other Gross PP&E Adjustments (2018 - 2025)
Historic Other Gross PP&E Adjustments for Esperion Therapeutics (ESPR) over the last 8 years, with Q3 2025 value amounting to -$3.3 million.
- Esperion Therapeutics' Other Gross PP&E Adjustments rose 4656.06% to -$3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.3 million, marking a year-over-year increase of 4656.06%. This contributed to the annual value of -$29.2 million for FY2024, which is 417.08% down from last year.
- Per Esperion Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$3.3 million for Q3 2025, which was up 4656.06% from -$4.2 million recorded in Q2 2025.
- Esperion Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at -$730000.0 during Q3 2022, with a 5-year trough of -$29.2 million in Q4 2024.
- Its 5-year average for Other Gross PP&E Adjustments is -$8.6 million, with a median of -$4.3 million in 2021.
- Per our database at Business Quant, Esperion Therapeutics' Other Gross PP&E Adjustments surged by 8487.16% in 2022 and then plummeted by 56325.58% in 2024.
- Quarter analysis of 5 years shows Esperion Therapeutics' Other Gross PP&E Adjustments stood at -$21.9 million in 2021, then dropped by 12.07% to -$24.6 million in 2022, then dropped by 14.3% to -$28.1 million in 2023, then decreased by 4.17% to -$29.2 million in 2024, then surged by 88.63% to -$3.3 million in 2025.
- Its last three reported values are -$3.3 million in Q3 2025, -$4.2 million for Q2 2025, and -$5.0 million during Q1 2025.